India based pharmaceutical company Laurus Labs agreed to acquire 100% shares of Phekolong Pharmaceuticals Pty Ltd, a wholly owned subsidiary of Aspen Pharmacare, South Africa.
Details are provided below:
- This deal will provide access to the South African public antiretroviral (ARV) sector to the company.
- Laurus Labs a research & development driven and fully integrated pharmaceutical firm
- The Laurus Labs is manufacturers of Active Pharmaceutical Ingredients (APIs) for anti-retroviral (ARV) and Hepatitis C.